{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:01:45Z","timestamp":1771257705755,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00066-023-02150-1","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T16:25:48Z","timestamp":1695140748000},"page":"827-831","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The benefit of intravenous immune globulin in the treatment of delayed radiation myelopathy"],"prefix":"10.1007","volume":"200","author":[{"given":"Saba","family":"Naghavi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Motahharynia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farnaz","family":"Fatemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaheh","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faezeh","family":"Mokhtari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4409-9404","authenticated-orcid":false,"given":"Iman","family":"Adibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"issue":"9701","key":"2150_CR1","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/S0140-6736(09)61299-X","volume":"374","author":"C Soussain","year":"2009","unstructured":"Soussain\u00a0C, Ricard\u00a0D, Fike\u00a0JR, Mazeron\u00a0J\u2011J, Psimaras\u00a0D, Delattre\u00a0J\u2011Y (2009) CNS complications of radiotherapy and chemotherapy. Lancet 374(9701):1639\u20131651. https:\/\/doi.org\/10.1016\/S0140-6736(09)61299-X","journal-title":"Lancet"},{"issue":"1","key":"2150_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s40425-019-0803-x","volume":"7","author":"M Carausu","year":"2019","unstructured":"Carausu\u00a0M, Beddok\u00a0A, Langer\u00a0A, Girard\u00a0N, Bidard\u00a0F\u2011C, Massiani\u00a0M\u2011A et al (2019) Radiation myelitis after pembrolizumab administration, with favorable clinical evolution and safe rechallenge: a\u00a0case report and review of the literature. J\u00a0Immunother Cancer 7(1):317. https:\/\/doi.org\/10.1186\/s40425-019-0803-x","journal-title":"J Immunother Cancer"},{"issue":"8","key":"2150_CR3","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/sc.2015.43","volume":"53","author":"CS Wong","year":"2015","unstructured":"Wong\u00a0CS, Fehlings\u00a0MG, Sahgal\u00a0A (2015) Pathobiology of radiation myelopathy and strategies to mitigate injury. Spinal Cord 53(8):574\u2013580. https:\/\/doi.org\/10.1038\/sc.2015.43","journal-title":"Spinal Cord"},{"issue":"4","key":"2150_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.4103\/1793-5482.106656","volume":"7","author":"F Sarica","year":"2012","unstructured":"Sarica\u00a0F, Ozgur\u00a0K, Cekinmez\u00a0M, Nur\u00a0A, Kadir\u00a0T (2012) Delayed radiation myelopathy: differential diagnosis with positron emission tomography\/computed tomography examination. Asian J Neurosurg 7(4):206. https:\/\/doi.org\/10.4103\/1793-5482.106656","journal-title":"Asian J Neurosurg"},{"issue":"7","key":"2150_CR5","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/leu.2009.26","volume":"23","author":"CB Reeder","year":"2009","unstructured":"Reeder\u00a0CB, Reece\u00a0DE, Kukreti\u00a0V, Chen\u00a0C, Trudel\u00a0S, Hentz\u00a0J et\u00a0al (2009) Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a\u00a0phase\u00a0II clinical trial. Leukemia 23(7):1337\u20131341. https:\/\/doi.org\/10.1038\/leu.2009.26","journal-title":"Leukemia"},{"issue":"9757","key":"2150_CR6","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0140-6736(10)62051-X","volume":"376","author":"GJ Morgan","year":"2010","unstructured":"Morgan\u00a0GJ, Davies\u00a0FE, Gregory\u00a0WM, Cocks\u00a0K, Bell\u00a0SE, Szubert\u00a0AJ et al (2010) First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a\u00a0randomised controlled trial. Lancet 376(9757):1989\u20131999. https:\/\/doi.org\/10.1016\/S0140-6736(10)62051-X","journal-title":"Lancet"},{"issue":"1","key":"2150_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1470-2045(18)30687-9","volume":"20","author":"GH Jackson","year":"2019","unstructured":"Jackson\u00a0GH, Davies\u00a0FE, Pawlyn\u00a0C, Cairns\u00a0DA, Striha\u00a0A, Collett\u00a0C et al (2019) Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a\u00a0multicentre, open-label, randomised, phase\u00a03\u00a0trial. Lancet Oncol 20(1):57\u201373. https:\/\/doi.org\/10.1016\/S1470-2045(18)30687-9","journal-title":"Lancet Oncol"},{"issue":"52","key":"2150_CR8","doi-asserted-by":"publisher","first-page":"e9389","DOI":"10.1097\/MD.0000000000009389","volume":"96","author":"P-C Hsu","year":"2017","unstructured":"Hsu\u00a0P\u2011C, Chen\u00a0S\u2011J (2017) Longitudinal extensive transverse myelitis with an abnormal uFLC ratio in a\u00a0pediatric patient. Medicine 96(52):e9389. https:\/\/doi.org\/10.1097\/MD.0000000000009389","journal-title":"Medicine"},{"issue":"10272","key":"2150_CR9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","volume":"397","author":"NWCJ van de Donk","year":"2021","unstructured":"van de Donk\u00a0NWCJ, Pawlyn\u00a0C, Yong\u00a0KL (2021) Multiple myeloma. Lancet 397(10272):410\u2013427. https:\/\/doi.org\/10.1016\/S0140-6736(21)00135-5","journal-title":"Lancet"},{"issue":"4","key":"2150_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s11523-017-0504-7","volume":"12","author":"ZT Al-Salama","year":"2017","unstructured":"Al-Salama\u00a0ZT, Garnock-Jones\u00a0KP, Scott\u00a0LJ (2017) Ixazomib: a\u00a0review in relapsed and\/or refractory multiple myeloma. Target Oncol 12(4):535\u2013542. https:\/\/doi.org\/10.1007\/s11523-017-0504-7","journal-title":"Target Oncol"},{"issue":"10","key":"2150_CR11","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1212\/WNL.44.10.1818","volume":"44","author":"DH Gilden","year":"1994","unstructured":"Gilden\u00a0DH, Beinlich\u00a0BR, Rubinstien\u00a0EM, Stommel\u00a0E, Swenson\u00a0R, Rubinstein\u00a0D et al (1994) Varicella-zoster virus myelitis: an expanding spectrum. Neurology 44(10):1818\u20131818. https:\/\/doi.org\/10.1212\/WNL.44.10.1818","journal-title":"Neurology"},{"issue":"1","key":"2150_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/cncr.24006","volume":"115","author":"E Vickrey","year":"2009","unstructured":"Vickrey\u00a0E, Allen\u00a0S, Mehta\u00a0J, Singhal\u00a0S (2009) Acyclovir to prevent reactivation of varicella zoster virus (herpes zoster) in multiple myeloma patients receiving bortezomib therapy. Cancer 115(1):229\u2013232. https:\/\/doi.org\/10.1002\/cncr.24006","journal-title":"Cancer"},{"issue":"8","key":"2150_CR13","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1001\/jamaneurol.2017.1336","volume":"74","author":"C Zhang","year":"2017","unstructured":"Zhang\u00a0C, Tian\u00a0D\u2011C, Yang\u00a0C\u2011S, Han\u00a0B, Wang\u00a0J, Yang\u00a0L et al (2017) Safety and efficacy of bortezomib in patients with highly relapsing neuromyelitis optica spectrum disorder. JAMA Neurol 74(8):1010. https:\/\/doi.org\/10.1001\/jamaneurol.2017.1336","journal-title":"JAMA Neurol"},{"issue":"6","key":"2150_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.reuma.2016.06.004","volume":"13","author":"EH Chiganer","year":"2017","unstructured":"Chiganer\u00a0EH, Hryb\u00a0JP, Carnero Contentti\u00a0E (2017) Mielitis y lupus: cl\u00ednica, diagn\u00f3stico y tratamiento. Revisi\u00f3n. Reumatol Cl\u00edn 13(6):344\u2013348. https:\/\/doi.org\/10.1016\/j.reuma.2016.06.004","journal-title":"Reumatol Cl\u00edn"},{"issue":"9","key":"2150_CR15","doi-asserted-by":"publisher","first-page":"969","DOI":"10.2169\/internalmedicine.52.7885","volume":"52","author":"H Yaguchi","year":"2013","unstructured":"Yaguchi\u00a0H, Sakushima\u00a0K, Takahashi\u00a0I, Nishimura\u00a0H, Yashima-Yamada\u00a0M, Nakamura\u00a0M et al (2013) Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder. Intern Med 52(9):969\u2013972. https:\/\/doi.org\/10.2169\/internalmedicine.52.7885","journal-title":"Intern Med"},{"key":"2150_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.6263","author":"A Feki","year":"2022","unstructured":"Feki\u00a0A, Sellami\u00a0I, Gassara\u00a0Z, Ben Djemaa\u00a0S, Ezzeddine\u00a0M, Kallel\u00a0MH et al (2022) Spinal Paget\u2019s disease with bilevel cord compression and ischemic non-compressive myelopathy treated with zoledronic acid. Clin Case Reports. https:\/\/doi.org\/10.1002\/ccr3.6263","journal-title":"Clin Case Reports"},{"key":"2150_CR17","doi-asserted-by":"publisher","DOI":"10.26502\/acmcr.96550034","author":"C Makranz","year":"2018","unstructured":"Makranz\u00a0C, Nachmias\u00a0B, Gatt\u00a0EM, Eliahou\u00a0R, Lossos\u00a0A (2018) Lenalidomide-related spinal cord infarction in primary amyloidosis. Arch Clin Med Case Rep. https:\/\/doi.org\/10.26502\/acmcr.96550034","journal-title":"Arch Clin Med Case Rep"},{"issue":"5","key":"2150_CR18","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.ijrobp.2007.11.075","volume":"71","author":"TE Schultheiss","year":"2008","unstructured":"Schultheiss\u00a0TE (2008) The radiation dose\u2013response of the human spinal cord. Int J Radiat Oncol 71(5):1455\u20131459. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.11.075","journal-title":"Int J Radiat Oncol"},{"issue":"2","key":"2150_CR19","doi-asserted-by":"publisher","first-page":"A67","DOI":"10.1227\/01.NEU.0000341628.98141.B6","volume":"64","author":"IC Gibbs","year":"2009","unstructured":"Gibbs\u00a0IC, Patil\u00a0C, Gerszten\u00a0PC, Adler\u00a0JR, Burton\u00a0SA (2009) Delayed Radiation-Induced Myelopathy After Spinal Radiosurgery. Neurosurgery 64(2):A67\u201372. https:\/\/doi.org\/10.1227\/01.NEU.0000341628.98141.B6","journal-title":"Neurosurgery"},{"key":"2150_CR20","doi-asserted-by":"publisher","unstructured":"Kubo K, Wadasaki K, Yamane H, Doi M. Radiation myelitis after durvalumab administration following chemoradiotherapy for locally advanced non-small cell lung cancer: an illustrative case report and review of the literature. Int Cancer Conf J [Internet]. 2019 Jul 13;8(3):118\u201321. Available from: https:\/\/doi.org\/10.1007\/s13691-019-00367-5","DOI":"10.1007\/s13691-019-00367-5"},{"key":"2150_CR21","doi-asserted-by":"publisher","unstructured":"Nozaki\u00a0S, Naiki\u00a0T, Hamamoto\u00a0S, Ando\u00a0R, Iida\u00a0K, Kawai\u00a0N et\u00a0al (2017) A\u00a0Case of Delayed Radiation Myelopathy of the Thoracic Vertebrae Following Low Dose Radiation Therapy for Metastatic Renal Cell Carcinoma. Urol Case Reports [Internet. Feb, vol 11. Available from, pp\u00a066\u201368 https:\/\/doi.org\/10.1016\/j.eucr.2017.01.005","DOI":"10.1016\/j.eucr.2017.01.005"},{"key":"2150_CR22","doi-asserted-by":"publisher","unstructured":"Liu CY, Yim BT, Wozniak AJ. Anticoagulation Therapy for Radiation-Induced Myelopathy. Ann Pharmacother [Internet]. 2001 Feb 26;35(2):188\u201391. Available from: https:\/\/doi.org\/10.1345\/aph.10168","DOI":"10.1345\/aph.10168"},{"key":"2150_CR23","doi-asserted-by":"publisher","unstructured":"Calabr\u00f2 F, Jinkins JR. MRI of radiation myelitis: a\u00a0report of a\u00a0case treated with hyperbaric oxygen. Eur Radiol [Internet]. 2000 Jun 21;10(7):1079\u201384. Available from: https:\/\/doi.org\/10.1007\/s003309900278","DOI":"10.1007\/s003309900278"},{"key":"2150_CR24","doi-asserted-by":"publisher","unstructured":"Psimaras D, Tafani C, Ducray F, Leclercq D, Feuvret L, Delattre JY, et\u00a0al. Bevacizumab in late-onset radiation-induced myelopathy. Neurology [Internet]. 2016 Feb 2;86(5):454\u20137. Available from: https:\/\/doi.org\/10.1212\/WNL.0000000000002345","DOI":"10.1212\/WNL.0000000000002345"},{"key":"2150_CR25","doi-asserted-by":"publisher","unstructured":"Khan M, Ambady P, Kimbrough D, Shoemaker T, Terezakis S, Blakeley J, et\u00a0al. Radiation-Induced Myelitis: Initial and Follow-Up MRI and Clinical Features in Patients at a\u00a0Single Tertiary Care Institution during 20 Years. Am J Neuroradiol [Internet]. 2018 May 17; Available from: https:\/\/doi.org\/10.3174\/ajnr.A5671","DOI":"10.3174\/ajnr.A5671"},{"key":"2150_CR26","doi-asserted-by":"publisher","unstructured":"van Doorn PA, Kuitwaard K, Walgaard C, van Koningsveld R, Ruts L, Jacobs BC. IVIG Treatment and Prognosis in Guillain\u2013Barr\u00e9 Syndrome. J\u00a0Clin Immunol [Internet]. 2010 May 16;30(S1):74\u20138. Available from: https:\/\/doi.org\/10.1007\/s10875-010-9407-4","DOI":"10.1007\/s10875-010-9407-4"},{"key":"2150_CR27","doi-asserted-by":"publisher","unstructured":"Tzekou A, Fehlings MG. Treatment of Spinal Cord Injury with Intravenous Immunoglobulin\u00a0G: Preliminary Evidence and Future Perspectives. J\u00a0Clin Immunol [Internet]. 2014 Jul 11;34(S1):132\u20138. Available from: https:\/\/doi.org\/10.1007\/s10875-014-0021-8","DOI":"10.1007\/s10875-014-0021-8"},{"key":"2150_CR28","doi-asserted-by":"publisher","unstructured":"Owen T, Fung AS. Combination Intravenous Immune Globulin (IVIG) and High Dose Steroids for Treatment of Immune-Related Myelitis in a\u00a0Non-Small Cell Lung Cancer Patient Treated With Pembrolizumab and Palliative Radiation Treatment: A\u00a0Case Report. Clin Lung Cancer [Internet]. 2022 Dec;23(8):e563\u20137. Available from: https:\/\/doi.org\/10.1016\/j.cllc.2022.08.012","DOI":"10.1016\/j.cllc.2022.08.012"},{"key":"2150_CR29","doi-asserted-by":"publisher","unstructured":"Marchioni E, Marinou-Aktipi K, Uggetti C, Bottanelli M, Pichiecchio A, Soragna D, et\u00a0al. Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis. J Neurol [Internet]. 2002 Jan;249(1):100\u20134. Available from: https:\/\/doi.org\/10.1007\/PL00007836","DOI":"10.1007\/PL00007836"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-023-02150-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-023-02150-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-023-02150-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T23:25:54Z","timestamp":1724455554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-023-02150-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["2150"],"URL":"https:\/\/doi.org\/10.1007\/s00066-023-02150-1","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,19]]},"assertion":[{"value":"24 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.\u00a0Naghavi, A.\u00a0Motahharynia, F.\u00a0Fatemi, E.\u00a0Ahmadi, F.\u00a0Mokhtari and I.\u00a0Adibi declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Iranian national committee for ethics in biomedical research (Approval ID: IR.ARI.MUI.REC.1401.123) and performed in accordance with the Helsinki Declaration of 1964, and its later amendment. <i>Consent to participate and Consent to publish:<\/i> Written informed consent and consent for publication were provided by the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}